Frozen confections containing probiotic micro-organisms
AssigneeNestec S.A.
InventorsAnnick Mercenier, Guenolee Prioult, Sophie Nutten
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of frozen yoghurt. In particular, the present invention provides frozen yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may bioactive heat treated probiotic micro-organisms, for example. The present inventions also relates to health benefits provided by these non-replicating probiotic micro-organisms.
Claims15
A frozen yoghurt composition comprising about 106 to 1012 cfu of non-replicating probiotic micro-organisms per serving, whereby the non-replicating probiotic micro-organisms are rendered non-replicating by a heat treatment at a temperature from 120 to 140° C., wherein the non-replicating probiotic micro-organisms are selected from the group consisting of Bifidobacterium longum NCC 3001, Bifidobacterium longum NCC 2705, Bifidobacterium breve NCC 2950, Bifidobacterium lactis NCC 2818, Lactobacillus johnsonii La1, Lactobacillus paracasei NCC 2461, Lactobacillus rhamnosus NCC 4007, Lactobacillus reuteri DSM17938, Lactobacillus reuteri ATCC55730, Streptococcus thermophilus NCC 2019, Streptococcus themophilus NCC 2059, Lactobacillus casei NCC 4006, Lactobacillus acidophilus NCC 3009, Lactobacillus casei ACA-DC 6002(NCC 1825), Escherichia coli Nissle, Lactobacillus bulgaricus NCC 15, Lactococcus lactis NCC 2287, and combinations thereof.
A method for the treatment of inflammatory disorders comprising the step of administering to an individual having an inflammatory disorder a frozen yoghurt composition comprising 0.005 mg-1000 mg of non-replicating probiotic micro-organisms per daily dose, whereby the non-replicating probiotic micro-organisms are rendered non-replicating by a heat treatment at a temperature from 120 to 140° C., wherein the non-replicating probiotic micro-organisms are selected from the group consisting of Bifidobacterium longum NCC 3001, Bifidobacterium longum NCC 2705, Bifidobacterium breve NCC 2950, Bifidobacterium lactis NCC 2818, Lactobacillus johnsonii La1, Lactobacillus paracasei NCC 2461, Lactobacillus rhamnosus NCC 4007, Lactobacillus reuteri DSM17938, Lactobacillus reuteri ATCC55730, Streptococcus thermophilus NCC 2019, Streptococcus thermophilus NCC 2059, Lactobacillus casei NCC 4006, Lactobacillus acidophilus NCC 3009, Lactobacillus casei ACA-DC 6002 (NCC 1825), Escherichia coli Nissle, Lactobacillus bulgaricus NCC 15, Lactococcus lactis NCC 2287, and combinations thereof.
A method for the treatment of disorders related to a compromised immune defense comprising the step of administering to an individual having a disorder related to a compromised immune defense a frozen yoghurt composition comprising 0.005 mg-1000 mg of non-replicating probiotic micro-organisms per daily dose, whereby the non-replicating probiotic micro-organisms are rendered non-replicating by a heat treatment at a temperature from 120 to 140° C., wherein the non-replicating probiotic micro-organisms are selected from the group consisting of Bifidobacterium longum NCC 3001, Bifidobacterium longum NCC 2705, Bifidobacterium breve NCC 2950, Bifidobacterium lactis NCC 2818, Lactobacillus johnsonii La1, Lactobacillus paracasei NCC 2461, Lactobacillus rhamnosus NCC 4007, Lactobacillus reuteri DSM17938, Lactobacillus reuteri ATCC55730, Streptococcus thermophilus NCC 2019, Streptococcus thermophilus NCC 2059, Lactobacillus casei NCC 4006, Lactobacillus acidophilus NCC 3009, Lactobacillus casei ACA-DC 6002 (NCC 1825), Escherichia coli Nissle, Lactobacillus bulgaricus NCC 15, Lactococcus lactis NCC 2287, and combinations thereof.
Dependencies are inferred from the claim text.